Rheumatoid Factor Titer as an Indicator of the Risk of Rheumatoid Arthritis Activity: Dose-Effect Analysis with the Restricted Cubic Spline Model. [PDF]
Peng XC, Yin R, Luo LP, Xu S, Shuai Z.
europepmc +1 more source
Low Incidence of Rheumatoid Factor and Autoantibodies in Nigerian Patients with Rheumatoid Arthritis [PDF]
Brian Greenwood, E M Herrick
openalex +1 more source
Designing the Next Generation of Biomaterials through Nanoengineering
Nanoengineering enables precise control over biomaterial interactions with living systems by tuning surface energy, defects, porosity, and crystallinity. This review highlights how these nanoscale design parameters drive advances in regenerative medicine, drug delivery, bioprinting, biosensing, and bioimaging, while outlining key translational ...
Ryan Davis Jr.+3 more
wiley +1 more source
Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis. [PDF]
Krishnan Pandarathodiyil A+4 more
europepmc +1 more source
Retracted: Comprehensive Medical Analysis of Clinical Diseases and Syndromes Based on Rheumatoid Factor Interfering Immune Blood Cell Damage. [PDF]
Engineering JOH.
europepmc +1 more source
Reference preparation to standardize results of serological tests for rheumatoid factor [PDF]
K M Fulford+2 more
openalex +1 more source
A schematic illustration of how noble metals can be used to create nanoparticles (NPs) or nanoclusters (NCs). Noble metal NPs, due to their plasmonic properties, enable photothermal therapy and surface‐enhanced Raman scattering (SERS). In contrast, NCs, which lack a plasmonic resonance band, exhibit fluorescence, making them ideal for bioimaging ...
David Esporrín‐Ubieto+3 more
wiley +1 more source
Clinical and laboratory pattern of patients with systemic lupus erythematosus seropositive for rheumatoid factor. [PDF]
Iaremenko O+3 more
europepmc +1 more source
Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13. [PDF]
Sakane H+9 more
europepmc +1 more source